The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The management of dysphagia in esophageal adenocarcinoma patients undergoing neoadjuvant chemotherapy: Can invasive tube feeding be avoided?
Jonathan Cools-Lartigue
No relevant relationships to disclose
Daniel Jones
No relevant relationships to disclose
Taline Zourikian
No relevant relationships to disclose
Mathieu Rousseau
No relevant relationships to disclose
Jonathan Spicer
No relevant relationships to disclose
Eleanor Eckert
No relevant relationships to disclose
Thierry Alcindor
No relevant relationships to disclose
Lorenzo Ferri
No relevant relationships to disclose